BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25103264)

  • 21. A standardized extract of Rhynchosia volubilis Lour. exerts a protective effect on benzalkonium chloride-induced mouse dry eye model.
    Kang SW; Kim KA; Lee CH; Yang SJ; Kang TK; Jung JH; Kim TJ; Oh SR; Jung SH
    J Ethnopharmacol; 2018 Apr; 215():91-100. PubMed ID: 29288830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A murine model of dry eye induced by an intelligently controlled environmental system.
    Chen W; Zhang X; Zhang J; Chen J; Wang S; Wang Q; Qu J
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1386-91. PubMed ID: 18385054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of topical infliximab in a mouse model of experimental dry eye.
    Li Z; Choi W; Oh HJ; Yoon KC
    Cornea; 2012 Nov; 31 Suppl 1():S25-31. PubMed ID: 23038030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Rat Model of Dry Eye Induced by Aerosol Exposure of Particulate Matter.
    Mu N; Wang H; Chen D; Wang F; Ji L; Zhang C; Li M; Lu P
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):39. PubMed ID: 35089331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye.
    Lin BW; Chen MZ; Fan SX; Chuck RS; Zhou SY
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):45-53. PubMed ID: 25491293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
    Oh HN; Kim CE; Lee JH; Yang JW
    Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical TSG-6 Administration Protects the Ocular Surface in Two Mouse Models of Inflammation-Related Dry Eye.
    Lee MJ; Kim DH; Ryu JS; Ko AY; Ko JH; Kim MK; Wee WR; Khwarg SI; Oh JY
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5175-81. PubMed ID: 26244293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of androgen on ultrastructure of corneal epithelium and function of the tear film in BALB/c mice.
    Li L; Kang Q; Wang S; Zheng X
    Cornea; 2015 Mar; 34(3):334-41. PubMed ID: 25532998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
    Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
    Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease.
    Simsek C; Dogru M; Shinzawa M; Den S; Kojima T; Iseda H; Suzuki M; Shibasaki Y; Yoshida N; Shimazaki J
    J Ocul Pharmacol Ther; 2019; 35(6):350-358. PubMed ID: 31259647
    [No Abstract]   [Full Text] [Related]  

  • 32. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
    Jirsova K; Brejchova K; Krabcova I; Filipec M; Al Fakih A; Palos M; Vesela V
    Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
    Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
    Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of ectodomain shedding of TNF receptor 1 in ocular surface.
    Sakimoto T; Ohnishi T; Ishimori A
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2419-23. PubMed ID: 24627147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome.
    Tseng CL; Hung YJ; Chen ZY; Fang HW; Chen KH
    PLoS One; 2016; 11(6):e0157982. PubMed ID: 27336157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cellular mechanisms of dry eye: from pathogenesis to treatment.
    Mantelli F; Massaro-Giordano M; Macchi I; Lambiase A; Bonini S
    J Cell Physiol; 2013 Dec; 228(12):2253-6. PubMed ID: 23696296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serine protease inhibitor A3K protects rabbit corneal endothelium from barrier function disruption induced by TNF-α.
    Hu J; Zhang Z; Xie H; Chen L; Zhou Y; Chen W; Liu Z
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5400-7. PubMed ID: 23821192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress.
    Yoon KC; Ahn KY; Choi W; Li Z; Choi JS; Lee SH; Park SH
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7267-73. PubMed ID: 21849424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.